BRIX1 and breast carcinoma: In addition, immunohistochemistry (IHC) analysis of 91 breast cancer tissues revealed that higher expression of BRIX1 was significantly associated with higher tumor/node/metastasis (TNM) stages and worse overall survival of patients (Figure 6C; Table S1, Supporting Information).